Pablo J. Cagnoni - 01 Feb 2023 Form 4 Insider Report for Rubius Therapeutics, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 01 Feb 2023
Net transaction value: -$2,112
SEC form: 4
Accepted by SEC: 01 Feb 2023, 20:41:05 UTC
Prior SEC filing: 31 Jan 2023
Next SEC filing: 21 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Kamocsay, attorney-in-fact

Key filing fact

Pablo J. Cagnoni filed Form 4 for Rubius Therapeutics, Inc. on 01 Feb 2023.

Key facts

This page summarizes Pablo J. Cagnoni's Form 4 filing for Rubius Therapeutics, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Feb 2023, 20:41.

Change

Previous filing in this sequence was filed on 31 Jan 2023.
Current net transaction value: -$2,112.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RUBY transaction

Common Stock

Sale

Transaction value: $2,112
Shares: -8,448
Change %: -11%
Price: $0.2500^*
Shares after: 66,082
Date: 01 Feb 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units for the Reporting Person, as previously disclosed on a Form 4 filed with the Securities and Exchange Commission on January 31, 2023. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.